{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:51:58Z","timestamp":1793375518494,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773517"],"award-info":[{"award-number":["81773517"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930124"],"award-info":[{"award-number":["81930124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82021005"],"award-info":[{"award-number":["82021005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2702905"],"award-info":[{"award-number":["2022YFC2702905"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver plays an important role in maintaining glucose homeostasis. We aimed to examine the associations of liver enzymes and hepatic steatosis index (HSI, a reliable biomarker for non-alcoholic fatty liver disease) in early pregnancy with subsequent GDM risk, as well as the potential mediation effects of lipid metabolites on the association between HSI and GDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a birth cohort, liver enzymes were measured in early pregnancy (6-15 gestational weeks, mean 10) among 6,860 Chinese women. Multivariable logistic regression was performed to examine the association between liver biomarkers and risk of GDM. Pearson partial correlation and least absolute shrinkage and selection operator (LASSO) regression were conducted to identify lipid metabolites that were significantly associated with HSI in a subset of 948 women. Mediation analyses were performed to estimate the mediating roles of lipid metabolites on the association of HSI with GDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Liver enzymes and HSI were associated with higher risks of GDM after adjustment for potential confounders, with ORs ranging from 1.42 to 2.24 for extreme-quartile comparisons (false discovery rate-adjusted\n                      <jats:italic>P<\/jats:italic>\n                      -trend \u22640.005). On the natural log scale, each SD increment of alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, and HSI was associated with a 1.15-fold (95% CI: 1.05, 1.26), 1.10-fold (1.01, 1.20), 1.21-fold (1.10, 1.32), 1.15-fold (1.04, 1.27), and 1.33-fold (1.18, 1.51) increased risk of GDM, respectively. Pearson partial correlation and LASSO regression identified 15 specific lipid metabolites in relation to HSI. Up to 52.6% of the association between HSI and GDM risk was attributed to the indirect effect of the HSI-related lipid score composed of lipid metabolites predominantly from phospholipids (e.g., lysophosphatidylcholine and ceramides) and triacylglycerol.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated liver enzymes and HSI in early pregnancy, even within a normal range, were associated with higher risks of GDM among Chinese pregnant women. The association of HSI with GDM was largely mediated by altered lipid metabolism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-023-02818-6","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T10:02:38Z","timestamp":1681725758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women"],"prefix":"10.1186","volume":"21","author":[{"given":"Ping","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-7945","authenticated-orcid":false,"given":"An","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-9230","authenticated-orcid":false,"given":"Xiong-Fei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"issue":"1","key":"2818_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","volume":"5","author":"HD McIntyre","year":"2019","unstructured":"McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"2818_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/jdi.12854","volume":"10","author":"C Gao","year":"2019","unstructured":"Gao C, Sun X, Lu L, Liu F, Yuan J. Prevalence of gestational diabetes mellitus in mainland China: A systematic review and meta-analysis. J Diabetes Investig. 2019;10(1):154\u201362.","journal-title":"J Diabetes Investig."},{"issue":"10290","key":"2818_CR3","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet."},{"issue":"5","key":"2818_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ajg.2016.43","volume":"111","author":"LR De Souza","year":"2016","unstructured":"De Souza LR, Berger H, Retnakaran R, Vlachou PA, Maguire JL, Nathens AB, et al. Non-alcoholic fatty liver disease in early pregnancy predicts dysglycemia in mid-pregnancy: prospective study. Am J Gastroenterol. 2016;111(5):665\u201370.","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"2818_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00125-018-4779-8","volume":"62","author":"SM Lee","year":"2019","unstructured":"Lee SM, Kwak SH, Koo JN, Oh IH, Kwon JE, Kim BJ, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia. 2019;62(2):238\u201348.","journal-title":"Diabetologia."},{"issue":"7","key":"2818_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis."},{"issue":"1","key":"2818_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cgh.2020.11.028","volume":"20","author":"GS Jones","year":"2022","unstructured":"Jones GS, Alvarez CS, Graubard BI, McGlynn KA. Agreement between the prevalence of nonalcoholic fatty liver disease determined by transient elastography and fatty liver indices. Clin Gastroenterol Hepatol. 2022;20(1):227-9.e2.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2818_CR8","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.2147\/DMSO.S335364","volume":"14","author":"S Song","year":"2021","unstructured":"Song S, Duo Y, Zhang Y, Qiao X, Xu J, Zhang J, et al. The predictive ability of hepatic steatosis index for gestational diabetes mellitus and large for gestational age infant compared with other noninvasive indices among Chinese pregnancies: a preliminary double-center cohort study. Diabetes Metab Syndr Obes. 2021;14:4791\u2013800.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"11","key":"2818_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrendo.2016.98","volume":"12","author":"X Han","year":"2016","unstructured":"Han X. Lipidomics for studying metabolism. Nat Rev Endocrinol. 2016;12(11):668\u201379.","journal-title":"Nat Rev Endocrinol."},{"issue":"10","key":"2818_CR10","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","volume":"56","author":"M Oresic","year":"2013","unstructured":"Oresic M, Hyotylainen T, Kotronen A, Gopalacharyulu P, Nygren H, Arola J, et al. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia. 2013;56(10):2266\u201374.","journal-title":"Diabetologia."},{"issue":"10","key":"2818_CR11","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","volume":"14","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Oresic M, Leivonen M, Gopalacharyulu P, Hyysalo J, Arola J, et al. Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites. Clin Gastroenterol Hepatol. 2016;14(10):1463-72.e6.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2818_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12944-021-01526-5","volume":"20","author":"YN Flores","year":"2021","unstructured":"Flores YN, Amoon AT, Su B, Velazquez-Cruz R, Ramirez-Palacios P, Salmeron J, et al. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico. Lipids Health Dis. 2021;20(1):136.","journal-title":"Lipids Health Dis."},{"issue":"4","key":"2818_CR13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46(4):1081\u201390.","journal-title":"Hepatology."},{"issue":"10","key":"2818_CR14","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/apt.16066","volume":"52","author":"Y Jung","year":"2020","unstructured":"Jung Y, Lee MK, Puri P, Koo BK, Joo SK, Jang SY, et al. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020;52(10):1603\u201314.","journal-title":"Aliment Pharmacol Ther."},{"issue":"5","key":"2818_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","volume":"64","author":"PK Luukkonen","year":"2016","unstructured":"Luukkonen PK, Zhou Y, Sadevirta S, Leivonen M, Arola J, Oresic M, et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol. 2016;64(5):1167\u201375.","journal-title":"J Hepatol."},{"key":"2818_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12986-017-0213-3","volume":"14","author":"C Papandreou","year":"2017","unstructured":"Papandreou C, Bullo M, Tinahones FJ, Martinez-Gonzalez MA, Corella D, Fragkiadakis GA, et al. Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial. Nutr Metab (Lond). 2017;14:58.","journal-title":"Nutr Metab (Lond)."},{"issue":"6","key":"2818_CR17","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/hep.23229","volume":"50","author":"P Puri","year":"2009","unstructured":"Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology. 2009;50(6):1827\u201338.","journal-title":"Hepatology."},{"issue":"5","key":"2818_CR18","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/ajcn\/nqab242","volume":"114","author":"Y Wang","year":"2021","unstructured":"Wang Y, Huang Y, Wu P, Ye Y, Sun F, Yang X, et al. Plasma lipidomics in early pregnancy and risk of gestational diabetes mellitus: a prospective nested case-control study in Chinese women. Am J Clin Nutr. 2021;114(5):1763\u201373.","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"2818_CR19","doi-asserted-by":"publisher","first-page":"e001551","DOI":"10.1136\/bmjdrc-2020-001551","volume":"9","author":"ML Rahman","year":"2021","unstructured":"Rahman ML, Feng YA, Fiehn O, Albert PS, Tsai MY, Zhu Y, et al. Plasma lipidomics profile in pregnancy and gestational diabetes risk: a prospective study in a multiracial\/ethnic cohort. BMJ Open Diabetes Res Care. 2021;9(1):e001551.","journal-title":"BMJ Open Diabetes Res Care."},{"issue":"5","key":"2818_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4103\/2230-8210.163172","volume":"19","author":"D Sanyal","year":"2015","unstructured":"Sanyal D, Mukherjee P, Raychaudhuri M, Ghosh S, Mukherjee S, Chowdhury S. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J Endocrinol Metab. 2015;19(5):597\u2013601.","journal-title":"Indian J Endocrinol Metab."},{"issue":"6","key":"2818_CR21","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.2337\/db10-1806","volume":"60","author":"F Bonnet","year":"2011","unstructured":"Bonnet F, Ducluzeau PH, Gastaldelli A, Laville M, Anderwald CH, Konrad T, et al. Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. Diabetes. 2011;60(6):1660\u20137.","journal-title":"Diabetes."},{"issue":"6","key":"2818_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00592-019-01458-8","volume":"57","author":"W Zhao","year":"2020","unstructured":"Zhao W, Zhang L, Zhang G, Varkaneh HK, Rahmani J, Clark C, et al. The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies. Acta Diabetol. 2020;57(6):635\u201344.","journal-title":"Acta Diabetol."},{"key":"2818_CR23","doi-asserted-by":"publisher","first-page":"27291","DOI":"10.1038\/srep27291","volume":"6","author":"J Leng","year":"2016","unstructured":"Leng J, Zhang C, Wang P, Li N, Li W, Liu H, et al. Plasma levels of alanine aminotransferase in the first trimester identify high risk Chinese women for gestational diabetes. Sci Rep. 2016;6:27291.","journal-title":"Sci Rep."},{"key":"2818_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3389\/fendo.2018.00581","volume":"9","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Hedderson MM, Quesenberry CP, Feng J, Ferrara A. Liver enzymes in early to mid-pregnancy, insulin resistance, and gestational diabetes risk: a longitudinal analysis. Front Endocrinol (Lausanne). 2018;9:581.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"2818_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/met.2015.0106","volume":"14","author":"CD Yarrington","year":"2016","unstructured":"Yarrington CD, Cantonwine DE, Seely EW, McElrath TF, Zera CA. The association of alanine aminotransferase in early pregnancy with gestational diabetes. Metab Syndr Relat Disord. 2016;14(5):254\u20138.","journal-title":"Metab Syndr Relat Disord."},{"issue":"7","key":"2818_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia."},{"issue":"21","key":"2818_CR27","doi-asserted-by":"publisher","first-page":"12812","DOI":"10.1021\/acs.est.9b04369","volume":"53","author":"Y Huang","year":"2019","unstructured":"Huang Y, Sun F, Tan H, Deng Y, Sun Z, Chen H, et al. DEHP and DINP induce tissue- and gender-specific disturbances in fatty acid and lipidomic profiles in neonatal mice: a comparative study. Environ Sci Technol. 2019;53(21):12812\u201322.","journal-title":"Environ Sci Technol."},{"issue":"3","key":"2818_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"BE Metzger","year":"2010","unstructured":"Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676\u201382.","journal-title":"Diabetes Care."},{"issue":"6","key":"2818_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"X-F Pan","year":"2021","unstructured":"Pan X-F, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373\u201392.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2818_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57(1):289\u2013300.","journal-title":"J R Statist Soc B."},{"issue":"4","key":"2818_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med."},{"key":"2818_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1467-9531.2007.00180.x","volume":"37","author":"PT von Hippel","year":"2007","unstructured":"von Hippel PT. Regression with missing Ys: an improved strategy for analyzing multiply imputed data. Sociol Methodol. 2007;37:83\u2013117.","journal-title":"Sociol Methodol."},{"issue":"1","key":"2818_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw."},{"key":"2818_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"2818_CR35","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.2337\/dc13-2229","volume":"37","author":"SB Sridhar","year":"2014","unstructured":"Sridhar SB, Xu F, Darbinian J, Quesenberry CP, Ferrara A, Hedderson MM. Pregravid liver enzyme levels and risk of gestational diabetes mellitus during a subsequent pregnancy. Diabetes Care. 2014;37(7):1878\u201384.","journal-title":"Diabetes Care."},{"issue":"1","key":"2818_CR36","doi-asserted-by":"publisher","first-page":"18695","DOI":"10.1038\/s41598-021-98180-9","volume":"11","author":"JY Park","year":"2021","unstructured":"Park JY, Kim WJ, Chung YH, Kim B, Park Y, Park IY, et al. Association between pregravid liver enzyme levels and gestational diabetes in twin pregnancies: a secondary analysis of national cohort study. Sci Rep. 2021;11(1):18695.","journal-title":"Sci Rep."},{"issue":"2","key":"2818_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12020-019-01954-5","volume":"65","author":"T Xiong","year":"2019","unstructured":"Xiong T, Zhong C, Sun G, Zhou X, Chen R, Li Q, et al. Early maternal circulating alkaline phosphatase with subsequent gestational diabetes mellitus and glucose regulation: a prospective cohort study in China. Endocrine. 2019;65(2):295\u2013303.","journal-title":"Endocrine."},{"issue":"9","key":"2818_CR38","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/liv.12840","volume":"35","author":"F Bril","year":"2015","unstructured":"Bril F, Ortiz-Lopez C, Lomonaco R, Orsak B, Freckleton M, Chintapalli K, et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver Int. 2015;35(9):2139\u201346.","journal-title":"Liver Int."},{"issue":"3","key":"2818_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","volume":"8","author":"AJ McCullough","year":"2004","unstructured":"McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8(3):521\u201333.","journal-title":"Clin Liver Dis."},{"issue":"1","key":"2818_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3350\/cmh.2021.0174","volume":"28","author":"SM Lee","year":"2022","unstructured":"Lee SM, Hwangbo S, Norwitz ER, Koo JN, Oh IH, Choi ES, et al. Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods. Clin Mol Hepatol. 2022;28(1):105\u201316.","journal-title":"Clin Mol Hepatol."},{"issue":"2","key":"2818_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","volume":"73","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang Y, Graham S, Wang X, Cai D, Huang M, et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J Hepatol. 2020;73(2):263\u201376.","journal-title":"J Hepatol."},{"issue":"2","key":"2818_CR42","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/hep.30226","volume":"70","author":"K Hajifathalian","year":"2019","unstructured":"Hajifathalian K, TorabiSagvand B, McCullough AJ. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study. Hepatology. 2019;70(2):511\u201321.","journal-title":"Hepatology."},{"issue":"4","key":"2818_CR43","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/jcsm.12719","volume":"12","author":"JH Moon","year":"2021","unstructured":"Moon JH, Koo BK, Kim W. Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey. J Cachexia Sarcopenia Muscle. 2021;12(4):964\u201372.","journal-title":"J Cachexia Sarcopenia Muscle."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02818-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02818-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02818-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T08:44:22Z","timestamp":1729241062000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02818-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2818"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02818-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Tongji Medical College, Huazhong University of Science and Technology (approval number: 2017-S225). All participants gave written informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}